// App-Quantinova.ai

4303 : Chemotherapy Toxicity Related to Non-Alcoholic Fatty Liver Disease (NAFLD) in an Adolescent with Pre-B Cell Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Rony Skaria

Principal Investigators

  • Maria G. Falcon

  • Victor Saldivar

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Nonalcoholic fatty liver disease

  • Acute lymphoblastic leukemia

  • Fatty Liver Disease

  • Peripheral neuropathy

  • Metabolic syndrome

  • Type 2 diabetes mellitus

  • Hypertension

  • Cirrhosis

  • Hyperbilirubinemia

  • Obesity

  • Anemia

  • Solid malignancies

  • Syndrome of inappropriate secretion of antidiuretic hormone

  • Nonalcoholic steatohepatitis

Biomarkers

  • Alanine transaminase

  • Aspartate aminotransferase

  • Breakpoint Cluster Region

  • Lactate dehydrogenase

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Allmercap

  • Daunorubicin

  • Methotrexate

  • Asparaginase

  • Vincristine

  • Cytarabine liposomal

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved